The Role of Ghrelin in Cancer Cachexia

Trial Profile

The Role of Ghrelin in Cancer Cachexia

Discontinued
Phase of Trial: Phase II

Latest Information Update: 28 Feb 2017

At a glance

  • Drugs Anamorelin (Primary)
  • Indications Cachexia; Non-small cell lung cancer
  • Focus Pharmacodynamics
  • Most Recent Events

    • 09 Aug 2016 Status changed from active, no longer recruiting to discontinued due to poor recruitment.
    • 02 Dec 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov .
    • 29 Jan 2014 Planned End Date changed from 1 Mar 2014 to 1 Mar 2016, as per ClinicalTrials.gov .
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top